Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.

Presents research which studied the effects of recombinant human growth hormone (rhGH) in patients with chronic heart failure due to dilated cardiomyopathy. Methods; Findings; Significant increase in left-ventricular mass in such patients given rhGH but without improvement in clinical status; Changes in left-ventricular mass due to changes in serum IGF-I concentrations; Unknown impact of longer treatment period with rhGH.